{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:24:11Z","timestamp":1784751851836,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["europeanneuropsychopharmacology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.euroneuro.2013.05.014","type":"journal-article","created":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T03:02:18Z","timestamp":1373425338000},"page":"1401-1407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Pharmacogenetic randomized trial for cocaine abuse: Disulfiram and \u03b11A-adrenoceptor gene variation"],"prefix":"10.1016","volume":"23","author":[{"given":"D.","family":"Shorter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.A.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.C.","family":"Hamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.R.","family":"Kosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2013.05.014_bib1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0006-3223(98)00296-0","article-title":"Alpha-1 noradrenergic receptor stimulation impairs prefrontal cortical cognitive function","volume":"45","author":"Arnstein","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.05.014_bib2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.drugalcdep.2006.08.016","article-title":"Disulfiram effects on responses to intravenous cocaine administration","volume":"87","author":"Baker","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2013.05.014_bib3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00213-005-0139-8","article-title":"Effects of dopamine beta-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice","volume":"183","author":"Bourdelat-Parks","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2013.05.014_bib4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/BF02287318","article-title":"The long-term outcomes of drug use by methadone maintenance patients","volume":"30","author":"Bovasso","year":"2003","journal-title":"J. Behav. Health Serv. Res."},{"key":"10.1016\/j.euroneuro.2013.05.014_bib5","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1471-4159.1990.tb04599.x","article-title":"Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals","volume":"55","author":"Carboni","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2013.05.014_bib7","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archpsyc.1997.01830220041007","article-title":"Manual-guided psychosocial treatment. A new virtual requirement for pharmacotherapy trials?","volume":"54","author":"Carroll","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.05.014_bib8","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1360-0443.1998.9357137.x","article-title":"Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram","volume":"93","author":"Carroll","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.euroneuro.2013.05.014_bib9","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/archpsyc.61.3.264","article-title":"Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients","volume":"61","author":"Carroll","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.05.014_bib10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.mp.4000657","article-title":"A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia","volume":"5","author":"Cubells","year":"2000","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.05.014_bib11","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0006-3223(01)01349-X","article-title":"Genotype-controlled analysis of plasma dopamine beta-hydroxylase activity in psychotic unipolar major depression","volume":"51","author":"Cubells","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.05.014_bib12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00213-004-1840-8","article-title":"Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology","volume":"174","author":"Cubells","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2013.05.014_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1124\/mi.9.4.6","article-title":"Mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse","volume":"9","author":"Gaval-Cruz","year":"2009","journal-title":"Mol. Interv."},{"key":"10.1016\/j.euroneuro.2013.05.014_bib15","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0006-3223(99)00310-8","article-title":"Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial","volume":"47","author":"George","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.05.014_bib16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrg1635","article-title":"The genetics of addictions: uncovering the genes","volume":"6","author":"Goldman","year":"2005","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.euroneuro.2013.05.014_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/00952999709001685","article-title":"Patterns and predictors of cocaine and crack use by clients in standard and enhanced methadone maintenance treatment","volume":"23","author":"Grella","year":"1997","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.euroneuro.2013.05.014_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/AJP.0b013e3181bff8b9","article-title":"Frequencies of polymorphisms in cytokines, neurotransmitters and adrenergic receptors in patients with complex regional pain syndrome type I after distal radial fracture","volume":"26","author":"Herlyn","year":"2010","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.euroneuro.2013.05.014_bib19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.clpt.2005.06.003","article-title":"Individual and joint association of alpha1A-adrenergic receptor Arg347Cys polymorphism and plasma irbesartan concentration with blood pressure therapeutic response in Chinese hypertensive subjects","volume":"78","author":"Jiang","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.euroneuro.2013.05.014_bib20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1517\/13543784.11.4.491","article-title":"The potential of dopamine agonists in drug addiction","volume":"11","author":"Kosten","year":"2002","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.euroneuro.2013.05.014_bib21","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00005053-198803000-00006","article-title":"Antecedents and consequences of cocaine abuse among opioid addicts. A 2.5-year follow-up","volume":"176","author":"Kosten","year":"1988","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.euroneuro.2013.05.014_bib22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.biopsych.2012.07.011","article-title":"Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine beta-hydroxylase","volume":"73","author":"Kosten","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.05.014_bib23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00210-005-1019-9","article-title":"Novel human alpha-1a-adrenocepter single nucleotide polymorphisms alter receptor pharmacology and biological function","volume":"371","author":"Lei","year":"2005","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.euroneuro.2013.05.014_bib24","doi-asserted-by":"crossref","first-page":"5713","DOI":"10.1523\/JNEUROSCI.22-13-05713.2002","article-title":"Blockade of stress-induced but not cocaine-induced reinstatement by infusion of noradrenergic antagonists into the bed nucleus of the stria terminalis or the nentral nucleus of the amygdala","volume":"22","author":"Leri","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2013.05.014_bib25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1300\/J069v17n04_07","article-title":"Changes in HIV risk behaviors among cocaine-using methadone patients","volume":"17","author":"Magura","year":"1998","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.euroneuro.2013.05.014_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0376-8716(98)00050-7","article-title":"Disulfiram effects on acute cocaine administration","volume":"52","author":"McCance-Katz","year":"1998","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2013.05.014_bib27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The fifth edition of the addiction severity index","volume":"9","author":"McLellan","year":"1992","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.euroneuro.2013.05.014_bib28","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","article-title":"Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation","volume":"284","author":"McLellan","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.euroneuro.2013.05.014_bib29","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1460-9568.2002.02104.x","article-title":"Intravenous cocaine induced-activity and behavioural sensitization in norepinephrine but not dopamine-transporter knockout mice","volume":"16","author":"Mead","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.euroneuro.2013.05.014_bib30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0376-8716(94)90092-2","article-title":"HIV infection and cocaine use in methadone maintained and untreated intravenous drug users","volume":"36","author":"Meandzija","year":"1994","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2013.05.014_bib31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0165-1781(86)90127-7","article-title":"Serum DBH activity in psychotic vs. nonpsychotic unipolar and bipolar depression","volume":"19","author":"Mod","year":"1986","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2013.05.014_bib32","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/JCP.0b013e31825ddbe6","article-title":"Functional polymorphism of the dopamine beta-hydroxylase gene is associated with increased risk of disulfiram-induced adverse effects in alcohol-dependent patients","volume":"32","author":"Mutschler","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.05.014_bib33","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1523\/JNEUROSCI.5735-03.2004","article-title":"Noradrenergic inhibition of midbrain dopamine neurons","volume":"24","author":"Paladini","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2013.05.014_bib34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1360-0443.2000.9522198.x","article-title":"Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts","volume":"95","author":"Petrakis","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.euroneuro.2013.05.014_bib35","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0091-3057(96)00408-X","article-title":"Modulation of vigilance and behavioral activation by alpha-1 adrenoceptors in the rat","volume":"56","author":"Puumalu","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2013.05.014_bib36","unstructured":"R_Development_Core_Team, 2009. R: A Language and Environment for Statistical Computing. Vienna, Austria, R Foundation for Statistical Computing."},{"key":"10.1016\/j.euroneuro.2013.05.014_bib37","first-page":"J16","article-title":"Effect of ACE inhibition on neurohormones","volume":"19","author":"Remme","year":"1998","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.euroneuro.2013.05.014_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2003.08.054","article-title":"Monoamine transporters and psychostimulant drugs","volume":"479","author":"Rothman","year":"2003","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.euroneuro.2013.05.014_bib39","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1038\/npp.2010.127","article-title":"Disulfiram attenuates drug-primed reinstatement of cocaine seeking via inhibition of dopamine beta-hydroxylase","volume":"35","author":"Schroeder","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2013.05.014_bib40","first-page":"22","article-title":"The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"issue":"9","key":"10.1016\/j.euroneuro.2013.05.014_bib41","first-page":"119","article-title":"Novel pharmacotherapeutic treatments for cocaine addiction","volume":"2011","author":"Shorter","year":"2012","journal-title":"BMC Med."},{"key":"10.1016\/j.euroneuro.2013.05.014_bib42","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.drugalcdep.2012.11.021","article-title":"The alpha-1 adrenergic antagonist doxazosin for treatment of cocaine dependence: a pilot study","volume":"131","author":"Shorter","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2013.05.014_bib43","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1042\/CS20020299","article-title":"Effects of common polymorphisms in the alpha1A-, alpha2B-, beta1- and beta2-adrenoceptors on haemodynamic responses to adrenaline","volume":"204","author":"Snapir","year":"2003","journal-title":"Clinic. Sci. (Lond)"},{"key":"10.1016\/j.euroneuro.2013.05.014_bib44","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/sj.bjp.0701315","article-title":"Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase","volume":"121","author":"Stanley","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2013.05.014_bib45","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/archpsyc.1983.01790060041005","article-title":"CSF dopamine beta-hydroxylase in schizophrenia","volume":"40","author":"Sternberg","year":"1983","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.05.014_bib46","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1176\/ajp.151.3.372","article-title":"CSF dopamine beta-hydroxylase in schizophrenia: associations with premorbid functioning and brain computerized tomography scan measures","volume":"151","author":"van Kammen","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.05.014_bib47","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/nm0910-969","article-title":"Cocaine sobers up","volume":"16","author":"Weinshenker","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.euroneuro.2013.05.014_bib48","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1520\/JFS2003221","article-title":"Methadone-related deaths in Palm Beach County","volume":"49","author":"Wolf","year":"2004","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.euroneuro.2013.05.014_bib49","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.biopsych.2005.02.003","article-title":"Prazosin, an alpha-1 adrenergic antagonist, reduces cocaine-induced reinstatement of drug-seeking","volume":"57","author":"Zhang","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.05.014_bib50","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/sj.npp.1301120","article-title":"Previous exposure to cocaine enhances cocaine self-administration in an alpha-1 adrenergic receptor dependent manner","volume":"32","author":"Zhang","year":"2007","journal-title":"Neuropsychopharmacology"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X13001764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X13001764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T19:11:11Z","timestamp":1563390671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X13001764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0924977X13001764"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2013.05.014","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718031639.793482413","asserted-by":"object"}]},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacogenetic randomized trial for cocaine abuse: Disulfiram and \u03b11A-adrenoceptor gene variation","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2013.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}